Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhexuan Yu
Institution:
Zhejiang Chinese Medical University
Observed institution:
Zhejiang Chinese Medical University
ORCID:
0000-0002-3783-9198
Observed ORCID:
0000-0002-3783-9198
OpenAlex ID:
A5103413525
Tanshinone IIA attenuates cerebral-ischemia-reperfusion-induced neuroinflammation by inhibiting the TLR4/NF-κB signaling cascade: A study integrating network pharmacology, bioinformatics, and experimental validation
2025
·
Chenxi Zhou
, Zhexuan Yu
, et al.
·
Phytomedicine
·
52
Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials
2026
·
Zhexuan Yu
, Bingyan Gu
, et al.
·
Frontiers in Medicine
·
3
PDF
Berberine Repairs Intestinal Mucosal Barrier by Targeting HSP90AA1 and MAPK14
2025
·
Danya Zhao
, Yang Zhai
, et al.
·
Pharmacogenomics and Personalized Medicine
·
2
Uncovering novel therapeutic clues for hypercoagulable active ulcerative colitis: novel findings from old data
2023
·
Zhexuan Yu
, Danya Zhao
, et al.
·
Gastroenterology report
·
2
PDF
Efficacy and safety of Naoxintong capsule for secondary prevention after reperfused acute myocardial infarction: a randomized, double-blind, placebo-controlled, multicenter trial
2026
·
Haitong Wan
, Sina Liu
, et al.
·
Phytomedicine
Show more works
View as search
Works count:
5
Citation count:
59
H-index:
2
I10-index:
1
Year
Topic
Type